Respiratory Syncytial Virus Infections
"Respiratory Syncytial Virus Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.
| Descriptor ID |
D018357
|
| MeSH Number(s) |
C02.782.580.600.620.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Respiratory Syncytial Virus Infections".
Below are MeSH descriptors whose meaning is more specific than "Respiratory Syncytial Virus Infections".
This graph shows the total number of publications written about "Respiratory Syncytial Virus Infections" by people in this website by year, and whether "Respiratory Syncytial Virus Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 1 | 4 |
| 1996 | 4 | 0 | 4 |
| 1997 | 2 | 0 | 2 |
| 1998 | 4 | 0 | 4 |
| 1999 | 6 | 1 | 7 |
| 2000 | 3 | 2 | 5 |
| 2001 | 4 | 1 | 5 |
| 2002 | 2 | 0 | 2 |
| 2003 | 7 | 1 | 8 |
| 2004 | 3 | 2 | 5 |
| 2005 | 4 | 1 | 5 |
| 2006 | 2 | 2 | 4 |
| 2007 | 6 | 1 | 7 |
| 2008 | 2 | 0 | 2 |
| 2009 | 5 | 0 | 5 |
| 2010 | 7 | 1 | 8 |
| 2011 | 5 | 0 | 5 |
| 2012 | 6 | 1 | 7 |
| 2013 | 5 | 1 | 6 |
| 2014 | 10 | 2 | 12 |
| 2015 | 10 | 2 | 12 |
| 2016 | 10 | 2 | 12 |
| 2017 | 9 | 2 | 11 |
| 2018 | 8 | 2 | 10 |
| 2019 | 7 | 3 | 10 |
| 2020 | 8 | 1 | 9 |
| 2021 | 12 | 0 | 12 |
| 2022 | 6 | 0 | 6 |
| 2023 | 14 | 0 | 14 |
| 2024 | 8 | 0 | 8 |
| 2025 | 12 | 0 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Respiratory Syncytial Virus Infections" by people in Profiles.
-
Single cell sequencing analysis of respiratory syncytial virus-infected pediatric and adult human nose organoids reveals age differences, proliferative diversity and identifies novel cellular tropism. J Infect. 2025 Oct; 91(4):106617.
-
Clinical Testing for COVID-19, Influenza, and RSV in Hospitalized Youths, 2016-2024. JAMA Netw Open. 2025 Sep 02; 8(9):e2531499.
-
Human Metapneumovirus and Respiratory Syncytial Virus in Children: A Comparative Analysis. Pediatrics. 2025 Sep 01; 156(3).
-
Oral dosing of the nucleoside analog obeldesivir is efficacious against RSV infection in African green monkeys. Nat Commun. 2025 Jul 11; 16(1):6437.
-
Complete genomic characterization of global pathogens respiratory syntical virus and human norovirus using probe based capture enrichment. Sci Rep. 2025 Jul 01; 15(1):20526.
-
Evaluation of a monoclonal antibody against respiratory syncytial virus, clesrovimab, in infants and children: Comprehensive rationale and study design for the late-stage clinical trials. Contemp Clin Trials. 2025 Oct; 157:107995.
-
Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025. MMWR Morb Mortal Wkly Rep. 2025 May 08; 74(16):273-281.
-
Mucosal vaccines with STING-agonist liposomal formulations inhibit RSV (respiratory syncytial virus) replication in cotton rats. Vaccine. 2025 May 22; 56:127183.
-
Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children. Expert Rev Anti Infect Ther. 2025 Jun; 23(6):359-378.
-
Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination. JAMA Netw Open. 2025 04 01; 8(4):e252841.